In vitro and in vivo effects of anti-tumor antibody covalently coupled to a chemotactic peptide.
D000818:Animals; D000912:Antibodies, Neoplasm / Q000008:administration & dosage*; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002630:Chemotactic Factors / Q000008:administration & dosage*; D002633:Chemotaxis / Q000187:drug effects; D006168:Guinea Pigs; D006801:Humans; D007167:Immunotherapy; D066298:In Vitro Techniques; D008114:Liver Neoplasms, Experimental / Q000503:physiopathology / Q000628:therapy; D008264:Macrophages / Q000503:physiopathology; D008297:Male; D009239:N-Formylmethionine / Q000008:administration & dosage / Q000031:analogs & derivatives; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009369:Neoplasms / Q000628:therapy*; D009842:Oligopeptides / Q000008:administration & dosage; D014677:Pharmaceutical Vehicles
D000912:Antibodies, Neoplasm; D000970:Antineoplastic Agents; D002630:Chemotactic Factors; D009842:Oligopeptides; D014677:Pharmaceutical Vehicles; D009239:N-Formylmethionine; D009240:N-Formylmethionine Leucyl-Phenylalanine